Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AXL is a receptor tyrosine kinase belonging to the TAM family. Upon ligand binding (primarily GAS6), AXL transduces signals promoting cell proliferation, survival, migration, invasion, and EMT. It regulates immune responses by inhibiting innate immunity and promoting clearance of apoptotic material. Overexpression of AXL is observed in various cancers, contributing to tumor growth, metastasis, and drug resistance, making it a therapeutic target.
Small molecule inhibition of AXL kinase activity, Antibody-mediated AXL inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Receptor tyrosine kinase AXL (AXL).